Report copyright - Cardio Diabetes Tour Manejo integral del Riesgo ... TOUR 2019... · 1.3 Rosiglitazona vs placebo o comparador activo Muerte Cardiovascular o Infarto Miocárdico H.R 1.43: 1.03-1.98
Please pass captcha verification before submit form